Assuta Medical Center, Tel Aviv, Israel.
Pristine Access Technologies, Tel Aviv, Israel.
J Vasc Access. 2022 Jan;23(1):128-134. doi: 10.1177/1129729820983617. Epub 2020 Dec 25.
The issue of side holes in the tips of the tunneled cuffed central venous catheters is complex and has been subject to longstanding debate. This study sought to compare the clotting potential of the side-hole-free Pristine hemodialysis catheter with that of a symmetric catheter with side holes.
Both jugular veins of five goats were catheterized with the two different catheters. The catheters were left in place for 4 weeks and were flushed and locked with heparin thrice weekly. The aspirated intraluminal clot length was assessed visually prior to each flushing. In addition, the size and weight of the clot were recorded upon catheter extraction at the end of the 4-week follow-up.
The mean intraluminal clot length observed during the entire study follow-up measured up to a mean of 0.66 cm in the GlidePath (95% CI, 0.14-1.18) and 0.19 cm in the Pristine hemodialysis catheter (95% CI, -0.33 to 0.71), the difference being statistically significant ( = 0.026). On average, 0.01 g and 0.07 g of intraluminal clot were retrieved from the Pristine and GlidePath catheters, respectively ( = 0.052).
The Pristine hemodialysis catheter was largely superior to a standard side hole catheter in impeding clot formation, and, contrary to the side hole catheter, allowed for complete aspiration of the intraluminal clot.
隧道带袖套中心静脉导管尖端侧孔的问题比较复杂,一直存在争议。本研究旨在比较无侧孔 Pristine 血液透析导管与带侧孔对称导管的血栓形成潜力。
对 5 只山羊的颈静脉分别使用两种不同的导管进行置管。导管留置 4 周,每周用肝素冲洗和封管 3 次。每次冲洗前,肉眼评估抽吸的管腔内血栓长度。此外,在 4 周随访结束时,从导管中取出时记录血栓的大小和重量。
整个研究随访期间,观察到的管腔内平均血栓长度在 GlidePath 组为 0.66cm(95%CI:0.14-1.18),在 Pristine 血液透析导管组为 0.19cm(95%CI:-0.33 至 0.71),差异有统计学意义( = 0.026)。平均从 Pristine 和 GlidePath 导管中取出的管腔内血栓分别为 0.01g 和 0.07g( = 0.052)。
与标准侧孔导管相比,Pristine 血液透析导管在阻止血栓形成方面具有明显优势,并且与侧孔导管不同,它允许完全抽吸管腔内的血栓。